Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution
Core Economic Terms of $6.0 Million Financing Remain Unchanged Jupiter Neurosciences, Inc. (NASDAQ:JUNS) JUPITER, FL, UNITED STATES, February 23, 2026 /EINPresswire.com/ -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage …